TTR and plasma cell myeloma: In addition to 18F-florbetapir, the use of 18F-florbetaben PET/CT for monitoring anti-inflammatory (AA), anti-myeloma (AL) and TTR-stabilizing (TTR) therapy were also evaluated [56].